159 related articles for article (PubMed ID: 16375588)
1. Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.
Kimak E; Ksiazek A; Solski J
Clin Chem Lab Med; 2006; 44(1):64-9. PubMed ID: 16375588
[TBL] [Abstract][Full Text] [Related]
2. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
3. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
4. A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients.
Kimak E; Solski J; Baranowicz-Gaszczyk I; Ksiazek A
Ren Fail; 2006; 28(6):483-6. PubMed ID: 16928617
[TBL] [Abstract][Full Text] [Related]
5. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
Kimak E; Solski J
Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
[TBL] [Abstract][Full Text] [Related]
6. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
[TBL] [Abstract][Full Text] [Related]
7. Alterations in lipoprotein composition in peritoneal dialysis patients.
Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
9. Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.
Kimak E; Bylina J; Solski J; Hałabiś M; Baranowicz-Gąszczyk I; Książek A
Cell Biochem Biophys; 2013 Nov; 67(2):695-702. PubMed ID: 23479335
[TBL] [Abstract][Full Text] [Related]
10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
[TBL] [Abstract][Full Text] [Related]
11. Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.
Kimak E; Hałabiś M; Baranowicz-Gaszczyk I
J Zhejiang Univ Sci B; 2010 Apr; 11(4):249-57. PubMed ID: 20349521
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
13. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII and E in patients with schizophrenia.
Wang J; Kockx M; Bolek M; Lambert T; Sullivan D; Chow V; Kritharides L
J Lipid Res; 2024 Jun; ():100577. PubMed ID: 38879166
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein profiles at different stages of chronic renal insufficiency.
Kimak E; Solski J; Janicka L
Ren Fail; 2000 Jan; 22(1):63-71. PubMed ID: 10718282
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipoproteins in patients with chronic renal failure (CRF).
Kimak E; Solski J; Janicka L; Duma D; Zagojska M
Int Urol Nephrol; 1997; 29(5):597-601. PubMed ID: 9413769
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Fytili CI; Progia EG; Panagoutsos SA; Thodis ED; Passadakis PS; Sombolos KI; Vargemezis VA
Ren Fail; 2002 Sep; 24(5):623-30. PubMed ID: 12380908
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of lipid parameters and bioindices in patients with different stages of chronic renal failure.
Cabarkapa V; Djerić M; Stosić Z; Sakac V; Zagorka LC; Vucković B
Vojnosanit Pregl; 2012 Nov; 69(11):961-6. PubMed ID: 23311247
[TBL] [Abstract][Full Text] [Related]
20. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
